Immunome, Inc. (IMNM) Reports Q2 Loss of $0.65
Tweet
Share
E-mailGet Alerts IMNM Hot Sheet
Join SI Premium – FREE
Immunome, Inc. (NASDAQ: IMNM) reported Q2 EPS of ($0.65), versus ($0.51) reported last year. Revenue for the quarter came in at $0 versus the consensus estimate of $181.82 thousand.
For earnings history and earnings-related data on Immunome, Inc. (IMNM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
- XP Inc eyes US banking license as next business step
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
